-
Domestic Infliximab Refreshes Low Price Again!
On April 18, 2022, the Shaanxi Provincial Public Resources Trading Center issued a notice on the dynamic adjustment of drug products listed on the Int...
2022-04-21 16:27 -
AbbVie Ends Partnership With BioArctic For Parkinson's Disease
AbbVie is ending an alpha-synuclein antibody collaboration agreement with BioArctic on Parkinson's disease and other movement disorders, according to ...
2022-04-21 16:17 -
Approval of The Clinical Trial Application of WuXi Giant Norricy Orenza Injection For r/r B-ALL
On April 20, WuXi Junuo announced that its CD19-targeting autologous chimeric antigen receptor T (CAR-T) cell immunotherapy product, Benoda® (Rigiore...
2022-04-21 15:33 -
The First Domestic Infliximab Price Adjustment
Recently, the Shaanxi Provincial Public Resource Trading Center issued a notice on the dynamic adjustment of drug products listed on the Internet to l...
2022-04-21 10:11 -
The First TCR-T Product For The Treatment of Liver Cancer Was Approved For Clinical Use
On April 20, Guangzhou Xiangxue Pharmaceutical announced that its grandson company Xiangxue Life Sciences TCR-T therapeutic product TAEST1901 injectio...
2022-04-21 10:00 -
Regeneron Acquires Checkmate for $250 Million, Gets TLR9 Agonist
On April 19, REGENERON and Checkmate jointly announced that the two companies have signed a definitive agreement under which Regeneron will acquire Ch...
2022-04-21 09:57 -
Market Analysis of Tetracycline and Chloramphenicol in Week 16
Doxycycline hydrochloride fell, and the market price was around 450, down 15% from the previous month.
2022-04-20 17:29 -
The World's First PI3Kδ/CK1ε Inhibitor Was Frustrated
On April 15, TG Therapeutics announced the voluntary withdrawal of the Biologics License Application (BLA)/Supplemental New Drug Application for the U...
2022-04-20 17:25 -
Japan's First! The Recombinant Protein COVID-19 Vaccine Introduced by Takeda Has Been Approved For M...
On April 19, Takeda announced that the new crown vaccine Nuvaxovid (NVX-CoV2373) has been approved for marketing in Japan for primary and booster immu...
2022-04-20 17:21 -
Anticancer Drug Is Expected to Become The First Domestic Oral Drug For covid-19, What Exactly Is Pro...
On April 6, Kintor Pharma announced the key data results of the Phase III global multi-center clinical trial (NCT04870606) of proclutamide in the trea...
2022-04-20 16:54
Hot News
- ExxonMobil Launches $10 Billio... Jul 17, 2025
- Global MDI/TDI Plants Enter Pe... Jul 23, 2025
- Europe Faces Unprecedented Pet... Jul 23, 2025
- Guangdong Jieyang Puts into Op... Jul 16, 2025
- BASF Launches Second Round of ... Jul 24, 2025
Related Products
Related Producers
